Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Panax Ginseng wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
11 of 12 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Armodafinil (Nuvigil) and Panax Ginseng have evidence — compare verdict strength side-by-side.
Approved dosing is 150–250 mg once daily in the morning for narcolepsy and OSA, or 150 mg taken ~1 hour before the start of a night shift for shift-work disorder. A prescription drug; off-label cognitive use is not an approved or standardized regimen.
morning
Oral tablet (armodafinil)
200-400mg standardized extract
Morning or early afternoon, With or without food
Standardized extract capsules
Hours (per dose); weeks for steady benefit
Per dose (acute)
Acute / weeks
Throughout use
2-4 weeks
4-8 weeks
If taken in evening
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Current medical research and opinion (2006) · Rct · n=196
Pivotal 12-week, multicenter, double-blind, placebo-controlled RCT in 196 narcolepsy patients (armodafinil 150 mg, 250 mg, or placebo once daily)
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Clinical therapeutics (2006) · Rct
12-week, 37-center, double-blind, placebo-controlled RCT of armodafinil 150 or 250 mg as adjunct in nCPAP-adherent OSA/hypopnea patients with residual excessive sleepiness
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
Mayo Clinic proceedings (2009) · Rct · n=254
12-week, 42-site, randomized, double-blind, placebo-controlled RCT in 254 night-shift workers with moderate-or-greater shift work disorder (armodafinil 150 mg vs placebo before each shift)
Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Review and Meta-Analysis
Phytotherapy research : PTR (2016) · Meta analysis · n=1843
The oxaliplatin plus TM groups showed significantly reduced CINV (risk ratio 0.65 [0.59, 0.71], I(2) = 28%) compared with oxaliplatin controls, with or without the addition of conventional anti-emetics.
Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
Nutrients (2023) · Meta analysis
Based on the scoring system, 2 (8%) supplements matched with the cluster of higher expected efficacy, 3 (12%) with the lower efficacy cluster and 20 (80%) matched with the criterion of no expected efficacy.
Exploratory Systematic Review and Meta-Analysis of Panax Genus Plant Ingestion Evaluation in Exercise Endurance
Nutrients (2022) · Meta analysis
We found that ingestion of PGPs or ginsenosides significantly improved exercise endurance (SMD [95% CI]: 0.58 [0.22-0.95], I2 = 0%).
Based on meta-analysis showing SMD 0.58 [0.22-0.95] with low heterogeneity. Effect attributed to ginsenoside Rg1 and PGPs extract. Conservative effectiveness estimates given limited dose-response data.
AI-estimated from published studies. Interpret as directional guidance.
Panax Ginseng has a higher evidence score (6/10 vs 5/10) and wins in 3 of 3 categories.
No known interactions between Armodafinil (Nuvigil) and Panax Ginseng have been documented in our database. However, always consult a healthcare provider before combining supplements.